Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of B Cell Response to MenC Vaccine in Children
NCT00310713Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2006
- Primary completion
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group c conjugate vaccine in Meningococcal infection caused by serogroup C Neisseria meningitidis, sponsored by Novartis. Started Apr 2006; status: completed.
02
Drugs
meningococcal group c conjugate vaccine
03
Conditions
Meningococcal infection caused by serogroup C Neisseria meningitidis
Beyond the preview
Go deeper on NCT00310713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310713.